|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01612 VINCENT MED
Nominal 
0.405 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 717,973 | 14.101% | 629,242 | 777,720 | 1,155,383 | 502,200 |
| Cost of Sales | (477,586) | 2.953% | (463,889) | (518,616) | (661,146) | (340,193) |
| Gross Profit | 240,387 | 45.378% | 165,353 | 259,104 | 494,237 | 162,007 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 2,817 | -- | (1,664) | (5,879) | (4,753) | (2,454) | |
| Profit / (Loss) before Taxation | 66,915 | -- | (15,516) | 66,180 | 284,084 | 18,294 | |
| Taxation | (8,707) | 202.958% | (2,874) | (6,110) | (36,649) | (5,437) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (933) | -- | 992 | 625 | (30,570) | (1,332) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 57,275 | -- | (17,398) | 60,695 | 216,865 | 11,525 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 985 | -57.942% | 2,342 | 2,046 | 3,167 | 2,483 |
| Depreciation & Amortisation | 38,331 | -6.400% | 40,952 | 40,063 | 37,016 | 28,553 |
| Directors' Emoluments | 6,856 | -5.369% | 7,245 | 6,912 | 11,081 | 6,793 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 8.870 | -- | -2.660 | 9.280 | 33.840 | 1.810 |
| DPS (cts) | 2.750 | -- | 2.500 | 4.500 | 11.000 | 1.100 |
| Dividend Payout Ratio (%) | 31.003% | -- | -- | 48.491% | 32.506% | 60.773% |
| Cash flow per share ($) | 0.194 | -- | 0.116 | 0.182 | 0.325 | 0.049 |
| NBV per share ($) | 0.829 | -- | 0.762 | 0.914 | 0.940 | 0.553 |
| Remarks: | Real time quote last updated: 14/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 33,288,000 |
| %Change | 25.143% |
| EPS / (LPS) | HKD 0.052 |
| NBV Per Share ($) | HKD 0.864 |